Anaconda Biomed
This medical device company develops endovascular access and protection systems for neurointerventions. Its primary product, the ANA5, is a self-expanding, nitinol-braid funnel catheter designed for mechanical thrombectomy in patients with acute ischemic stroke due to large vessel occlusion. The technology aims to provide local flow restriction and high-efficiency aspiration to reduce embolic risk during clot retrieval.
Visit websiteBarcelona, Spain
Healthtech
Medtech
Medical Devices
Biotechnology
Funding summary
- Total raised
- €35.0M
- Funding rounds
- 2
Investors in Anaconda Biomed
Investors on record for Anaconda Biomed. Click any investor to view their CAPLINK profile and funding criteria.
Fundraising for a startup like Anaconda Biomed?
Explore CAPLINK's investor database of thousands of active VCs and angels.
Browse investors